[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @MSollender Michelle Solly Michelle Solly posts on X about $abvx, $rare, $eidx, $bbio the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1063180083769176064/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +35% - X Months XXXXXXXXX +18% - X Year XXXXXXXXX +1,568% ### Mentions: XX [#](/creator/twitter::1063180083769176064/posts_active)  - X Month XX -XX% - X Months XXX +7.50% - X Year XXX +1,339% ### Followers: XXXXXX [#](/creator/twitter::1063180083769176064/followers)  - X Week XXXXXX +0.33% - X Month XXXXXX +1.40% - X Months XXXXXX +3.90% - X Year XXXXXX +7.90% ### CreatorRank: XXXXXXX [#](/creator/twitter::1063180083769176064/influencer_rank)  ### Social Influence [#](/creator/twitter::1063180083769176064/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$abvx](/topic/$abvx) #21, [$rare](/topic/$rare) 3.09%, [$eidx](/topic/$eidx) 2.06%, [$bbio](/topic/$bbio) 2.06%, [$cytk](/topic/$cytk) 2.06%, [debt](/topic/debt) 2.06%, [$dyn](/topic/$dyn) 2.06%, [dyne therapeutics](/topic/dyne-therapeutics) 2.06%, [$atai](/topic/$atai) 2.06%, [atai life](/topic/atai-life) XXXX% **Top accounts mentioned or mentioned by** [@pcmbio](/creator/undefined) [@sportsbios](/creator/undefined) [@biotenic](/creator/undefined) [@jq1234t](/creator/undefined) [@lipa0902](/creator/undefined) [@cloisterres](/creator/undefined) [@pawcio2009](/creator/undefined) [@seedy19tron](/creator/undefined) [@dmitrykovalchuk](/creator/undefined) [@nolastevedore](/creator/undefined) [@adar170](/creator/undefined) [@sanctuary_bio](/creator/undefined) [@downhillcap](/creator/undefined) [@tucaman123](/creator/undefined) [@articainabf](/creator/undefined) [@wyv_123](/creator/undefined) [@drsprs](/creator/undefined) [@biostocks](/creator/undefined) [@cloud_walker200](/creator/undefined) [@nkt0509](/creator/undefined) **Top assets mentioned** [SuperRare (RARE)](/topic/$rare) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [ATAI Life Sciences (ATAI)](/topic/$atai) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Incyte Corporation (INCY)](/topic/$incy) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Insmed, Inc. (INSM)](/topic/$insm) [Geron Corp (GERN)](/topic/$gern) ### Top Social Posts [#](/creator/twitter::1063180083769176064/posts) --- Top posts by engagements in the last XX hours "$EIDX $BBIO Amended proposal filing shows Company C with a competing offer for EIDX at $120/sh"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1337413003323445249) 2020-12-11 15:04:42 UTC 13.1K followers, XX engagements "$PRQR ProQR Therapeutics and Yarrow Biotechnology an RTW Investments LP Incubated Company Announce Exclusive Worldwide License and Discovery Collaboration for Undisclosed Target $115m upfront"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1389538044462571520) 2021-05-04 11:11:00 UTC 13.1K followers, XX engagements "$CYTK Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy DEC XX 2025"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1918037054149320977) 2025-05-01 20:17:23 UTC 13.1K followers, 10.6K engagements "$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943039211726344343) 2025-07-09 20:07:02 UTC 13.1K followers, 16.7K engagements "$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1945575395128217899) 2025-07-16 20:04:55 UTC 13.1K followers, 14.4K engagements "$ATAI atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1939992011496624461) 2025-07-01 10:18:33 UTC 13.1K followers, 1983 engagements "$DYN Dyne Therapeutics Secures Up to $XXX Million in Debt Financing from Hercules Capital"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1939776792174465044) 2025-06-30 20:03:21 UTC 13.1K followers, 5468 engagements "$INCY Incyte Appoints Bill Meury Chief Executive Officer; Herv Hoppenot to Retire Previously of Karuna Therapeutics Julian Baker elected Chairman of the Board of Directors"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1938199599522746422) 2025-06-26 11:36:09 UTC 13.1K followers, 8320 engagements "$ABVX XX mg once-daily dose of obefazimod led to a compelling pooled XXXX% (p0.0001) placebo-adjusted clinical remission rate at Week X in the ABTECT-1 (Study 105) and ABTECT-2 (Study 106) trials"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1947751810607026547) 2025-07-22 20:13:13 UTC 13.1K followers, 2514 engagements "$ATAI atai Life Sciences Announces $XX Million Private Placement Financing Ferring Ventures S.A. and Apeiron Investment Ltd. with Ally Bridge Group and ADAR1"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1939992129042067509) 2025-07-01 10:19:01 UTC 13.1K followers, 3186 engagements "$LSAC $VINC LifeSci Acquisition Corp. Announces Merger Agreement with Vincera Pharma Inc Stockholders include Acuta RTW Surveyor Logos EcoR1 Perceptive Advisors Boxer Monashee Altium and Affinity Asset Advisors"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1310917283703713798) 2020-09-29 12:20:10 UTC 13.1K followers, XX engagements "$BMY Bristol Myers Squibb Announces Topline Results from Phase X ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Fail"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1914776634768695563) 2025-04-22 20:21:39 UTC 13.1K followers, 3471 engagements "$BBIO $EIDX Two large biopharma companies were interested in a possible acquisition of EIDX in 2019 In 2020 a third company approached EIDX for a potential licensing and collaboration"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1324844721261301760) 2020-11-06 22:42:50 UTC 13.1K followers, XX engagements "$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1947751594671673714) 2025-07-22 20:12:22 UTC 13.1K followers, 12.5K engagements "Varda Announces $XXX million in Series C Funding to Make Medicines in Space Can't we just make them on Earth first"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943265903975780795) 2025-07-10 11:07:50 UTC 13.1K followers, 22.9K engagements "(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940005423534547058) 2025-07-01 11:11:51 UTC 13.1K followers, 51.2K engagements "@jq1234t So does that mean if you're less than X month out and you haven't gotten a CRL you're approved 🤔"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943786169999012244) 2025-07-11 21:35:11 UTC 13.1K followers, 1521 engagements "$CAPR Well that one didn't work out nearly as well as I wanted to as a trade but the obvious outcome was the obvious outcome ✅"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943666034134929456) 2025-07-11 13:37:48 UTC 13.1K followers, 5676 engagements "$APLS Apellis to Receive up to $XXX Million from Royalty Purchase Agreement with Sobi forEx-U.S. Royalties of Aspaveli (systemic pegcetacoplan)"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940003228596453848) 2025-07-01 11:03:07 UTC 13.1K followers, 2557 engagements "$ABVX (Also a highly acquisitive space cough cough). Gonna guess it's not going to be too late to add for a while"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1947753149672132783) 2025-07-22 20:18:33 UTC 13.1K followers, 11.8K engagements "$KYMR Interesting Kymera had decided last year not to advance their previous oncology pipeline past Ph1 (MDM2 and STAT3) but now has entered into a collaboration with $GILD for CDK2 degraders $85m upfront up to $750m in milestones"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1937945753194008782) 2025-06-25 18:47:27 UTC 13.1K followers, 5469 engagements "$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1924617438211277122) 2025-05-20 00:05:29 UTC 13.1K followers, 58.2K engagements "$INSM Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1932393110556082404) 2025-06-10 11:03:14 UTC 13.1K followers, 17.2K engagements "$GERN Geron Announces FDA Approval of RYTELO (imetelstat) a First-in-Class Telomerase Inhibitor for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1798898822426525832) 2024-06-07 02:04:35 UTC 13.1K followers, 14.7K engagements "Wow $ABVX better than I expected 2/2 so far $ATYR up next in the next 4-6 weeks ✅✅❔"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1947752478654796281) 2025-07-22 20:15:53 UTC 13.1K followers, 15.6K engagements "$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943770441400955246) 2025-07-11 20:32:41 UTC 13.1K followers, 18.2K engagements "$JSPR Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway Amazing"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1942923647980884452) 2025-07-09 12:27:50 UTC 13.1K followers, 5305 engagements "(2/3) Here are some slated for 2H25 Those that are specifically in 4Q25 are not listed yet $BIOA $CABA $CNTA $DRUG"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940005635040620615) 2025-07-01 11:12:41 UTC 13.1K followers, 3756 engagements "$CYTK Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS and the FDA accepted the NDA for filing. Recently during the NDA review the FDA requested that Cytokinetics submit a REMS Oh"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1918041002880749854) 2025-05-01 20:33:05 UTC 13.1K followers, 8301 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MSollender Michelle Solly
Michelle Solly posts on X about $abvx, $rare, $eidx, $bbio the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +35%
- X Months XXXXXXXXX +18%
- X Year XXXXXXXXX +1,568%
Mentions: XX #
- X Month XX -XX%
- X Months XXX +7.50%
- X Year XXX +1,339%
Followers: XXXXXX #
- X Week XXXXXX +0.33%
- X Month XXXXXX +1.40%
- X Months XXXXXX +3.90%
- X Year XXXXXX +7.90%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX%
Social topic influence $abvx #21, $rare 3.09%, $eidx 2.06%, $bbio 2.06%, $cytk 2.06%, debt 2.06%, $dyn 2.06%, dyne therapeutics 2.06%, $atai 2.06%, atai life XXXX%
Top accounts mentioned or mentioned by @pcmbio @sportsbios @biotenic @jq1234t @lipa0902 @cloisterres @pawcio2009 @seedy19tron @dmitrykovalchuk @nolastevedore @adar170 @sanctuary_bio @downhillcap @tucaman123 @articainabf @wyv_123 @drsprs @biostocks @cloud_walker200 @nkt0509
Top assets mentioned SuperRare (RARE) BridgeBio Pharma, Inc. Common Stock (BBIO) Cytokinetics Inc. (CYTK) Dyne Therapeutics, Inc. Common Stock (DYN) ATAI Life Sciences (ATAI) Sarepta Therapeutics, Inc. (SRPT) Incyte Corporation (INCY) Bristol-Myers Squibb Co (BMY) Apogee Therapeutics, Inc. Common Stock (APGE) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Scholar Rock Holding Corporation Common Stock (SRRK) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Gilead Sciences, Inc. (GILD) Kymera Therapeutics, Inc. Common Stock (KYMR) Pfizer, Inc. (PFE) Insmed, Inc. (INSM) Geron Corp (GERN)
Top Social Posts #
Top posts by engagements in the last XX hours
"$EIDX $BBIO Amended proposal filing shows Company C with a competing offer for EIDX at $120/sh"
@MSollender on X 2020-12-11 15:04:42 UTC 13.1K followers, XX engagements
"$PRQR ProQR Therapeutics and Yarrow Biotechnology an RTW Investments LP Incubated Company Announce Exclusive Worldwide License and Discovery Collaboration for Undisclosed Target $115m upfront" @MSollender on X 2021-05-04 11:11:00 UTC 13.1K followers, XX engagements
"$CYTK Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy DEC XX 2025" @MSollender on X 2025-05-01 20:17:23 UTC 13.1K followers, 10.6K engagements
"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis" @MSollender on X 2025-07-09 20:07:02 UTC 13.1K followers, 16.7K engagements
"$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label" @MSollender on X 2025-07-16 20:04:55 UTC 13.1K followers, 14.4K engagements
"$ATAI atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression" @MSollender on X 2025-07-01 10:18:33 UTC 13.1K followers, 1983 engagements
"$DYN Dyne Therapeutics Secures Up to $XXX Million in Debt Financing from Hercules Capital" @MSollender on X 2025-06-30 20:03:21 UTC 13.1K followers, 5468 engagements
"$INCY Incyte Appoints Bill Meury Chief Executive Officer; Herv Hoppenot to Retire Previously of Karuna Therapeutics Julian Baker elected Chairman of the Board of Directors" @MSollender on X 2025-06-26 11:36:09 UTC 13.1K followers, 8320 engagements
"$ABVX XX mg once-daily dose of obefazimod led to a compelling pooled XXXX% (p0.0001) placebo-adjusted clinical remission rate at Week X in the ABTECT-1 (Study 105) and ABTECT-2 (Study 106) trials" @MSollender on X 2025-07-22 20:13:13 UTC 13.1K followers, 2514 engagements
"$ATAI atai Life Sciences Announces $XX Million Private Placement Financing Ferring Ventures S.A. and Apeiron Investment Ltd. with Ally Bridge Group and ADAR1" @MSollender on X 2025-07-01 10:19:01 UTC 13.1K followers, 3186 engagements
"$LSAC $VINC LifeSci Acquisition Corp. Announces Merger Agreement with Vincera Pharma Inc Stockholders include Acuta RTW Surveyor Logos EcoR1 Perceptive Advisors Boxer Monashee Altium and Affinity Asset Advisors" @MSollender on X 2020-09-29 12:20:10 UTC 13.1K followers, XX engagements
"$BMY Bristol Myers Squibb Announces Topline Results from Phase X ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Fail" @MSollender on X 2025-04-22 20:21:39 UTC 13.1K followers, 3471 engagements
"$BBIO $EIDX Two large biopharma companies were interested in a possible acquisition of EIDX in 2019 In 2020 a third company approached EIDX for a potential licensing and collaboration" @MSollender on X 2020-11-06 22:42:50 UTC 13.1K followers, XX engagements
"$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis" @MSollender on X 2025-07-22 20:12:22 UTC 13.1K followers, 12.5K engagements
"Varda Announces $XXX million in Series C Funding to Make Medicines in Space Can't we just make them on Earth first" @MSollender on X 2025-07-10 11:07:50 UTC 13.1K followers, 22.9K engagements
"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE" @MSollender on X 2025-07-01 11:11:51 UTC 13.1K followers, 51.2K engagements
"@jq1234t So does that mean if you're less than X month out and you haven't gotten a CRL you're approved 🤔" @MSollender on X 2025-07-11 21:35:11 UTC 13.1K followers, 1521 engagements
"$CAPR Well that one didn't work out nearly as well as I wanted to as a trade but the obvious outcome was the obvious outcome ✅" @MSollender on X 2025-07-11 13:37:48 UTC 13.1K followers, 5676 engagements
"$APLS Apellis to Receive up to $XXX Million from Royalty Purchase Agreement with Sobi forEx-U.S. Royalties of Aspaveli (systemic pegcetacoplan)" @MSollender on X 2025-07-01 11:03:07 UTC 13.1K followers, 2557 engagements
"$ABVX (Also a highly acquisitive space cough cough). Gonna guess it's not going to be too late to add for a while" @MSollender on X 2025-07-22 20:18:33 UTC 13.1K followers, 11.8K engagements
"$KYMR Interesting Kymera had decided last year not to advance their previous oncology pipeline past Ph1 (MDM2 and STAT3) but now has entered into a collaboration with $GILD for CDK2 degraders $85m upfront up to $750m in milestones" @MSollender on X 2025-06-25 18:47:27 UTC 13.1K followers, 5469 engagements
"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion" @MSollender on X 2025-05-20 00:05:29 UTC 13.1K followers, 58.2K engagements
"$INSM Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension" @MSollender on X 2025-06-10 11:03:14 UTC 13.1K followers, 17.2K engagements
"$GERN Geron Announces FDA Approval of RYTELO (imetelstat) a First-in-Class Telomerase Inhibitor for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia" @MSollender on X 2024-06-07 02:04:35 UTC 13.1K followers, 14.7K engagements
"Wow $ABVX better than I expected 2/2 so far $ATYR up next in the next 4-6 weeks ✅✅❔" @MSollender on X 2025-07-22 20:15:53 UTC 13.1K followers, 15.6K engagements
"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)" @MSollender on X 2025-07-11 20:32:41 UTC 13.1K followers, 18.2K engagements
"$JSPR Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway Amazing" @MSollender on X 2025-07-09 12:27:50 UTC 13.1K followers, 5305 engagements
"(2/3) Here are some slated for 2H25 Those that are specifically in 4Q25 are not listed yet $BIOA $CABA $CNTA $DRUG" @MSollender on X 2025-07-01 11:12:41 UTC 13.1K followers, 3756 engagements
"$CYTK Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS and the FDA accepted the NDA for filing. Recently during the NDA review the FDA requested that Cytokinetics submit a REMS Oh" @MSollender on X 2025-05-01 20:33:05 UTC 13.1K followers, 8301 engagements